Tulane University School of Medicine

CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)

No phaseNot yet recruiting2026900 people28 Nov 2025clinicaltrials.gov

Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

No phaseRecruiting20231,176 people15 Nov 2023clinicaltrials.gov

Caribbean and South America Team-based Strategy to Control Hypertension

Phase 3Completed20231,706 people6 Jun 2022clinicaltrials.gov

Sodium Lowering Vascular Effects Trial

No phaseActive, not recruiting2023256 people24 May 2022clinicaltrials.gov

Medication Adherence Program

No phaseActive, not recruiting2022402 people11 Jan 2022clinicaltrials.gov

NCT05170789

Phase 2Withdrawn20220 people28 Dec 2021clinicaltrials.gov

NCT04865029

Phase 2Terminated202110 people29 Apr 2021clinicaltrials.gov

Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

No phaseActive, not recruiting20191,306 people15 Mar 2021clinicaltrials.gov

Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis

Phase 4Withdrawn20260 people23 Oct 2020clinicaltrials.gov

China Antihypertensive Trial in Acute Ischemic Stroke II

Phase 3Completed20184,810 people27 Mar 2018clinicaltrials.gov

NCT02958345

Phase 4Completed201328 people8 Nov 2016clinicaltrials.gov

NCT02796170

Phase 4Completed201611 people10 Jun 2016clinicaltrials.gov

NCT02299388

Phase 4Completed201411 people24 Nov 2014clinicaltrials.gov

NCT00165178

CollaboratorPhase 3Completed2000498 people14 Sept 2005clinicaltrials.gov